Post-transplant lymphoproliferative disorder (PTLD)

ValidICD-10-CM diagnosis code.

Valid for claims with a date of service in the current code year.

Valid FY2016 onwards.

What has happened to this code

Every change the publisher made, from 2010 to now. Entries marked draft are from the pre-implementation releases: ICD-10 took effect on 1 October 2015, so nothing before FY2016 was ever valid on a claim.

FY2010 Added to the draft code set draft Post-transplant lymphoproliferative disorder (PTLD)

Official coding rules

Published by CDC for FY2027. A rule attached to a category binds every code beneath it, so the rules inherited from this code's ancestors are shown with the code they come from.

Inherited from the D37-D48 section Neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes (D37-D48)

Excludes1 - never coded here

neoplasms of unspecified behavior (D49.-)

Note

Categories D37-D44, and D48 classify by site neoplasms of uncertain behavior, i.e., histologic confirmation whether the neoplasm is malignant or benign cannot be made.

How CDC's index refers to this code

Wording from the official alphabetic index. Much of it appears nowhere in the code description, which is why a search for the everyday phrase so often finds nothing.

Status > transplant
Transplant > complication
Complication > reimplant NEC > organ
Complication > organ or tissue transplant
History > personal > surgery NEC > transplant
Complication > surgical procedure > transplant
Status > organ replacement > by organ transplant
Disorder > post-transplant lymphoproliferative
Disorder > lymphoproliferative, post-transplant
Complication > transplant > post-transplant lymphoproliferative disorder

Codes in the same group

Code	Description	Status
D47.Z2	Castleman disease	Valid
D47.Z9	Other specified neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue	Valid